{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Renal cell carcinoma, part 3

Activity Steps

Learning Objectives

After completing this continuing education activity you will be able to:

  1. Recognize staging procedures to assess renal masses.
  2. Select recommended treatment options for patients with RCC.
  3. Choose appropriate assessment strategies for patients undergoing treatment for RCC.
  4. Identify patient education essential for patients undergoing treatment for RCC.

Learning Outcomes

Healthcare providers will demonstrate competency in clinical reasoning regarding treatment options and nursing care for patients with RCC by achieving a minimum score of 70% on the outcomes-based posttest.
Price: $24.95

Credits:

  • ANCC 2.5 CH / 1.0 APH
  • DC - BON 2.5 CH
  • FL - BON 2.5 CH
  • GA - BON 2.5 CH

Lippincott Professional Development is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, and Georgia Board of Nursing, #50-1223.

Awarded Advanced Pharmacology Hours







Test Code: N0921A
Published: September 2021
Expires: 6/7/2024
Sources: Nursing2024
Required Passing Score: 8/10 (80%)
Authors: RICHARD L. PULLEN, JR., EdD, MSN, RN, CMSRN, CNE-CL, CNE, ANEF